| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Central Nervous System Neoplasms | 4 | 2020 | 803 | 1.500 |
Why?
|
| Herpesvirus 2, Saimiriine | 9 | 2000 | 71 | 1.270 |
Why?
|
| Neural Tube | 4 | 2016 | 58 | 0.800 |
Why?
|
| Retinal Neoplasms | 1 | 2021 | 141 | 0.790 |
Why?
|
| Pathology, Surgical | 1 | 2020 | 141 | 0.770 |
Why?
|
| Immunohistochemistry | 7 | 2021 | 12095 | 0.750 |
Why?
|
| Retinoblastoma | 1 | 2021 | 315 | 0.730 |
Why?
|
| Supratentorial Neoplasms | 1 | 2019 | 155 | 0.720 |
Why?
|
| Chondroma | 1 | 2018 | 63 | 0.710 |
Why?
|
| Transcription Factor RelA | 1 | 2019 | 290 | 0.710 |
Why?
|
| Glioma | 6 | 2021 | 3110 | 0.700 |
Why?
|
| Trans-Activators | 6 | 2021 | 3150 | 0.680 |
Why?
|
| Skull Neoplasms | 1 | 2018 | 188 | 0.650 |
Why?
|
| Facial Bones | 1 | 2018 | 206 | 0.640 |
Why?
|
| Ependymoma | 1 | 2019 | 319 | 0.630 |
Why?
|
| Fibroma | 1 | 2018 | 227 | 0.620 |
Why?
|
| Simplexvirus | 8 | 2004 | 828 | 0.570 |
Why?
|
| Herpesvirus 1, Equid | 6 | 1998 | 7 | 0.530 |
Why?
|
| Homeodomain Proteins | 2 | 2021 | 2531 | 0.490 |
Why?
|
| Viral Proteins | 7 | 1999 | 1996 | 0.490 |
Why?
|
| Open Reading Frames | 8 | 2000 | 855 | 0.490 |
Why?
|
| Herpesvirus 1, Human | 5 | 1999 | 747 | 0.470 |
Why?
|
| Genetic Vectors | 8 | 2004 | 3628 | 0.470 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2021 | 1310 | 0.470 |
Why?
|
| Gene Expression Regulation, Developmental | 8 | 2016 | 3964 | 0.450 |
Why?
|
| Genes, Viral | 5 | 2000 | 781 | 0.450 |
Why?
|
| Lymphoma | 1 | 2020 | 1863 | 0.440 |
Why?
|
| Immediate-Early Proteins | 3 | 1998 | 465 | 0.420 |
Why?
|
| NF-kappa B | 1 | 2019 | 2553 | 0.410 |
Why?
|
| Transcription Factors | 8 | 2016 | 11910 | 0.410 |
Why?
|
| Viral Envelope Proteins | 6 | 1999 | 607 | 0.390 |
Why?
|
| Cytoskeletal Proteins | 5 | 2000 | 1494 | 0.370 |
Why?
|
| Symporters | 3 | 2015 | 376 | 0.370 |
Why?
|
| Bone Neoplasms | 1 | 2021 | 2597 | 0.360 |
Why?
|
| Pancreas | 2 | 2013 | 1716 | 0.350 |
Why?
|
| Brain Neoplasms | 7 | 2021 | 8590 | 0.340 |
Why?
|
| Adenomatous Polyposis Coli | 2 | 1997 | 211 | 0.310 |
Why?
|
| Viral Structural Proteins | 2 | 1998 | 111 | 0.300 |
Why?
|
| Base Sequence | 20 | 2016 | 13729 | 0.290 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 4 | 2014 | 1154 | 0.290 |
Why?
|
| Thymidine Kinase | 3 | 2004 | 318 | 0.290 |
Why?
|
| Bromodeoxyuridine | 1 | 2004 | 362 | 0.270 |
Why?
|
| Transcriptional Activation | 4 | 2016 | 1889 | 0.260 |
Why?
|
| Transcription, Genetic | 6 | 2009 | 8130 | 0.260 |
Why?
|
| Neurogenesis | 2 | 2014 | 845 | 0.260 |
Why?
|
| Proteins | 1 | 2019 | 6264 | 0.260 |
Why?
|
| Gene Expression Regulation, Viral | 5 | 2000 | 485 | 0.260 |
Why?
|
| Chromatin | 2 | 2014 | 2503 | 0.250 |
Why?
|
| Central Nervous System | 1 | 2009 | 1216 | 0.230 |
Why?
|
| Transducin | 1 | 2020 | 49 | 0.220 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 2 | 2013 | 146 | 0.220 |
Why?
|
| Luminescent Proteins | 3 | 2000 | 911 | 0.220 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2021 | 94 | 0.210 |
Why?
|
| Spinal Cord | 4 | 2016 | 1857 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 7 | 2009 | 6150 | 0.210 |
Why?
|
| Virion | 2 | 1998 | 426 | 0.200 |
Why?
|
| Molecular Sequence Data | 19 | 2015 | 19328 | 0.200 |
Why?
|
| Receptor, trkB | 1 | 2020 | 134 | 0.200 |
Why?
|
| Oncogene Fusion | 1 | 2019 | 112 | 0.190 |
Why?
|
| Herpes Simplex Virus Protein Vmw65 | 1 | 1998 | 32 | 0.190 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2004 | 3983 | 0.190 |
Why?
|
| Ribonuclease III | 1 | 2020 | 256 | 0.190 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 131 | 0.180 |
Why?
|
| Viral Fusion Proteins | 1 | 1998 | 96 | 0.180 |
Why?
|
| Aneuploidy | 1 | 2021 | 461 | 0.180 |
Why?
|
| Mitotic Index | 1 | 2018 | 181 | 0.180 |
Why?
|
| Homeostasis | 1 | 2009 | 3297 | 0.180 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2020 | 345 | 0.170 |
Why?
|
| Thermus thermophilus | 1 | 1997 | 26 | 0.170 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 1318 | 0.170 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2018 | 82 | 0.170 |
Why?
|
| Chick Embryo | 4 | 2016 | 1010 | 0.170 |
Why?
|
| Lymphoma, T-Cell | 1 | 2020 | 319 | 0.170 |
Why?
|
| Demyelinating Diseases | 1 | 2019 | 337 | 0.160 |
Why?
|
| California | 1 | 2021 | 1399 | 0.160 |
Why?
|
| Leukemia | 1 | 2004 | 1449 | 0.160 |
Why?
|
| Adenosine Triphosphatases | 4 | 1997 | 909 | 0.160 |
Why?
|
| Oncogene Proteins, Fusion | 3 | 2020 | 1548 | 0.160 |
Why?
|
| Astrocytoma | 1 | 2020 | 777 | 0.150 |
Why?
|
| Humans | 50 | 2022 | 686663 | 0.150 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2016 | 301 | 0.150 |
Why?
|
| Jurkat Cells | 3 | 2004 | 827 | 0.150 |
Why?
|
| Mouth Diseases | 1 | 2018 | 264 | 0.150 |
Why?
|
| Trypsin | 1 | 2015 | 546 | 0.140 |
Why?
|
| Microtubules | 2 | 1998 | 1215 | 0.140 |
Why?
|
| Stromal Cells | 1 | 2000 | 1385 | 0.140 |
Why?
|
| Capsid | 2 | 1998 | 427 | 0.140 |
Why?
|
| DNA-Binding Proteins | 6 | 1998 | 9934 | 0.140 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2019 | 474 | 0.140 |
Why?
|
| Adolescent | 12 | 2021 | 84957 | 0.140 |
Why?
|
| Genetic Testing | 2 | 2020 | 3230 | 0.140 |
Why?
|
| DNA Repair | 5 | 1998 | 2035 | 0.140 |
Why?
|
| Child | 10 | 2021 | 71361 | 0.130 |
Why?
|
| Neocortex | 1 | 1997 | 401 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2020 | 900 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-beta | 1 | 2013 | 61 | 0.130 |
Why?
|
| Meningioma | 1 | 2022 | 1128 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1997 | 1111 | 0.130 |
Why?
|
| Cytoskeleton | 1 | 1998 | 1231 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 1998 | 1105 | 0.130 |
Why?
|
| Meningeal Neoplasms | 1 | 2022 | 1147 | 0.130 |
Why?
|
| Genetic Markers | 1 | 2020 | 2775 | 0.120 |
Why?
|
| Pituitary Neoplasms | 1 | 2021 | 1234 | 0.120 |
Why?
|
| Consensus Sequence | 1 | 2013 | 398 | 0.120 |
Why?
|
| Mice, Transgenic | 5 | 2016 | 10094 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2019 | 4716 | 0.120 |
Why?
|
| Escherichia coli Proteins | 2 | 1997 | 1134 | 0.120 |
Why?
|
| Binding Sites | 9 | 2015 | 6499 | 0.120 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2016 | 784 | 0.120 |
Why?
|
| Green Fluorescent Proteins | 4 | 2004 | 2238 | 0.120 |
Why?
|
| Protein Binding | 7 | 2015 | 9947 | 0.120 |
Why?
|
| Colony-Forming Units Assay | 3 | 2002 | 386 | 0.120 |
Why?
|
| Child, Preschool | 6 | 2021 | 41159 | 0.110 |
Why?
|
| Aotidae | 2 | 2004 | 62 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2016 | 533 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2021 | 1826 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2018 | 1942 | 0.110 |
Why?
|
| Cell Line, Transformed | 4 | 2000 | 1026 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 2 | 2018 | 1616 | 0.110 |
Why?
|
| Work | 1 | 2012 | 201 | 0.110 |
Why?
|
| Animals | 29 | 2020 | 170849 | 0.110 |
Why?
|
| Agriculture | 1 | 2012 | 210 | 0.110 |
Why?
|
| Herpesvirus 4, Human | 1 | 1997 | 1221 | 0.110 |
Why?
|
| Parietal Lobe | 1 | 2016 | 808 | 0.110 |
Why?
|
| Young Adult | 9 | 2021 | 56052 | 0.110 |
Why?
|
| Neuroblastoma | 1 | 1997 | 1144 | 0.100 |
Why?
|
| Antigens, Surface | 1 | 1995 | 1904 | 0.100 |
Why?
|
| Histones | 1 | 2020 | 2566 | 0.100 |
Why?
|
| K562 Cells | 2 | 2004 | 662 | 0.100 |
Why?
|
| Oligopeptides | 2 | 2015 | 1305 | 0.100 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 730 | 0.100 |
Why?
|
| Metabolism | 1 | 2011 | 231 | 0.100 |
Why?
|
| 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 1 | 2009 | 75 | 0.100 |
Why?
|
| Neural Inhibition | 1 | 2014 | 609 | 0.100 |
Why?
|
| Sarcoma | 1 | 2020 | 1822 | 0.100 |
Why?
|
| Translocation, Genetic | 1 | 2015 | 1440 | 0.100 |
Why?
|
| Cloning, Molecular | 8 | 1997 | 4671 | 0.100 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2009 | 83 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2019 | 1477 | 0.100 |
Why?
|
| Physical Exertion | 1 | 2012 | 723 | 0.100 |
Why?
|
| DNA Primers | 5 | 2013 | 3121 | 0.100 |
Why?
|
| Colorectal Neoplasms | 3 | 2004 | 6323 | 0.100 |
Why?
|
| Mice | 15 | 2020 | 80803 | 0.090 |
Why?
|
| Cells, Cultured | 9 | 2013 | 20620 | 0.090 |
Why?
|
| Cerebellum | 1 | 2016 | 1492 | 0.090 |
Why?
|
| Mutation | 10 | 2021 | 28848 | 0.090 |
Why?
|
| Blotting, Western | 5 | 2013 | 5678 | 0.090 |
Why?
|
| Vision Disorders | 1 | 2016 | 978 | 0.090 |
Why?
|
| Genetic Loci | 2 | 2015 | 2575 | 0.090 |
Why?
|
| DNA Mismatch Repair | 2 | 2021 | 376 | 0.090 |
Why?
|
| Male | 18 | 2021 | 352465 | 0.090 |
Why?
|
| Peptides | 2 | 2000 | 4537 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2013 | 2772 | 0.090 |
Why?
|
| Stem Cells | 5 | 2016 | 3612 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 1 | 2020 | 2884 | 0.090 |
Why?
|
| Boston | 1 | 2021 | 9534 | 0.080 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2016 | 993 | 0.080 |
Why?
|
| Cell Line | 5 | 2013 | 17137 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2019 | 3059 | 0.080 |
Why?
|
| Software | 1 | 2021 | 4314 | 0.080 |
Why?
|
| Antigens, Neoplasm | 1 | 1995 | 2176 | 0.080 |
Why?
|
| Neurons | 4 | 2014 | 9331 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5223 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2004 | 5015 | 0.080 |
Why?
|
| Prognosis | 4 | 2021 | 28923 | 0.080 |
Why?
|
| Blotting, Southern | 2 | 1999 | 847 | 0.080 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1252 | 0.080 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 488 | 0.080 |
Why?
|
| Genome | 3 | 2021 | 1681 | 0.080 |
Why?
|
| Neoplasm Proteins | 2 | 2015 | 3972 | 0.080 |
Why?
|
| Female | 17 | 2021 | 375459 | 0.080 |
Why?
|
| Carrier Proteins | 1 | 2000 | 5257 | 0.080 |
Why?
|
| Amino Acid Transport Systems | 1 | 2005 | 37 | 0.070 |
Why?
|
| Biopsy | 1 | 2018 | 6849 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1997 | 770 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 1721 | 0.070 |
Why?
|
| Movement | 1 | 2012 | 1449 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2009 | 4716 | 0.070 |
Why?
|
| Low Back Pain | 1 | 2012 | 822 | 0.070 |
Why?
|
| COS Cells | 3 | 2009 | 1261 | 0.070 |
Why?
|
| Transfection | 3 | 2004 | 6329 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15407 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 427 | 0.070 |
Why?
|
| Ganciclovir | 1 | 2004 | 265 | 0.070 |
Why?
|
| Occupational Diseases | 1 | 2012 | 1492 | 0.060 |
Why?
|
| Seizures | 1 | 2016 | 2410 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 5 | 1997 | 6464 | 0.060 |
Why?
|
| Drug Industry | 1 | 2011 | 904 | 0.060 |
Why?
|
| Bacterial Proteins | 2 | 1997 | 4155 | 0.060 |
Why?
|
| Bone Marrow Cells | 2 | 2002 | 2698 | 0.060 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 14656 | 0.060 |
Why?
|
| beta Catenin | 3 | 1997 | 1063 | 0.060 |
Why?
|
| E-Box Elements | 2 | 2014 | 18 | 0.060 |
Why?
|
| DNA | 2 | 2013 | 7320 | 0.060 |
Why?
|
| Zinc Fingers | 2 | 2016 | 611 | 0.060 |
Why?
|
| Adult | 9 | 2021 | 211400 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2012 | 1791 | 0.060 |
Why?
|
| Middle Aged | 9 | 2021 | 216468 | 0.060 |
Why?
|
| Adenomatous Polyposis Coli Protein | 2 | 2000 | 188 | 0.060 |
Why?
|
| DNA, Viral | 3 | 1996 | 2341 | 0.060 |
Why?
|
| Lysine | 2 | 2020 | 1036 | 0.060 |
Why?
|
| Kanamycin Kinase | 1 | 2000 | 35 | 0.050 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 2 | 1997 | 12 | 0.050 |
Why?
|
| Flow Cytometry | 3 | 2002 | 6230 | 0.050 |
Why?
|
| Chromosome Mapping | 4 | 1998 | 4952 | 0.050 |
Why?
|
| Biological Transport, Active | 1 | 2000 | 385 | 0.050 |
Why?
|
| Gene Expression | 4 | 2015 | 8182 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2000 | 516 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1999 | 6835 | 0.050 |
Why?
|
| Mesoderm | 1 | 2002 | 749 | 0.050 |
Why?
|
| Genes, Neoplasm | 1 | 2021 | 402 | 0.050 |
Why?
|
| Genes, APC | 1 | 2000 | 175 | 0.050 |
Why?
|
| Nocodazole | 1 | 1998 | 114 | 0.050 |
Why?
|
| Second Messenger Systems | 1 | 2000 | 227 | 0.050 |
Why?
|
| Neoplasms | 2 | 2000 | 19538 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2020 | 59331 | 0.050 |
Why?
|
| Amino Acids | 1 | 2005 | 1717 | 0.050 |
Why?
|
| HT29 Cells | 1 | 1999 | 216 | 0.050 |
Why?
|
| Phosphorylation | 4 | 2000 | 8896 | 0.050 |
Why?
|
| Infant | 4 | 2021 | 33918 | 0.050 |
Why?
|
| Cycloheximide | 1 | 1998 | 373 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 3 | 2022 | 8610 | 0.050 |
Why?
|
| Mutagenesis | 2 | 2020 | 1312 | 0.050 |
Why?
|
| Casein Kinase II | 1 | 1998 | 122 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1663 | 0.040 |
Why?
|
| Palate, Hard | 1 | 2018 | 56 | 0.040 |
Why?
|
| Codon, Initiator | 1 | 1998 | 57 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 482 | 0.040 |
Why?
|
| Antigens, CD34 | 1 | 2000 | 672 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 2000 | 675 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3557 | 0.040 |
Why?
|
| Multidrug Resistance-Associated Proteins | 1 | 1998 | 109 | 0.040 |
Why?
|
| Genes, Immediate-Early | 1 | 1998 | 103 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 3006 | 0.040 |
Why?
|
| Vero Cells | 1 | 1998 | 473 | 0.040 |
Why?
|
| Methylation | 1 | 2020 | 1126 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2000 | 3018 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2020 | 827 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2003 | 787 | 0.040 |
Why?
|
| Cell Separation | 1 | 2002 | 1874 | 0.040 |
Why?
|
| Hormones | 1 | 2000 | 777 | 0.040 |
Why?
|
| Aged | 6 | 2020 | 162271 | 0.040 |
Why?
|
| Baculoviridae | 1 | 1996 | 124 | 0.040 |
Why?
|
| Spodoptera | 1 | 1996 | 163 | 0.040 |
Why?
|
| Ribonucleoproteins | 1 | 1999 | 413 | 0.040 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 540 | 0.040 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 1158 | 0.040 |
Why?
|
| Cartilage, Articular | 1 | 2003 | 1038 | 0.040 |
Why?
|
| Mice, Inbred C3H | 2 | 1996 | 1162 | 0.040 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2021 | 761 | 0.040 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2020 | 634 | 0.040 |
Why?
|
| Chromosomes, Fungal | 1 | 1995 | 138 | 0.040 |
Why?
|
| Protein Kinases | 2 | 2005 | 1706 | 0.040 |
Why?
|
| Glutamate Carboxypeptidase II | 1 | 1995 | 86 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2000 | 2481 | 0.040 |
Why?
|
| Biomedical Research | 1 | 2011 | 3285 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2833 | 0.040 |
Why?
|
| Escherichia coli | 3 | 2015 | 4411 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1778 | 0.040 |
Why?
|
| Genetic Variation | 1 | 2011 | 6772 | 0.040 |
Why?
|
| Documentation | 1 | 2021 | 806 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 2013 | 2064 | 0.040 |
Why?
|
| Magnesium | 1 | 1998 | 864 | 0.040 |
Why?
|
| Antiviral Agents | 2 | 2004 | 2625 | 0.040 |
Why?
|
| Electroporation | 1 | 2016 | 266 | 0.040 |
Why?
|
| Cricetinae | 1 | 1998 | 2624 | 0.040 |
Why?
|
| Embryo, Mammalian | 2 | 2013 | 1843 | 0.030 |
Why?
|
| Cell Differentiation | 5 | 2016 | 11833 | 0.030 |
Why?
|
| Yeasts | 1 | 1995 | 300 | 0.030 |
Why?
|
| Nucleotides | 1 | 1996 | 424 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1995 | 336 | 0.030 |
Why?
|
| Age of Onset | 1 | 2021 | 3373 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1995 | 438 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 2009 | 8262 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1999 | 935 | 0.030 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 1998 | 370 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2021 | 4415 | 0.030 |
Why?
|
| Restriction Mapping | 2 | 1991 | 939 | 0.030 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 623 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 23439 | 0.030 |
Why?
|
| Cell Nucleus | 3 | 1999 | 3092 | 0.030 |
Why?
|
| PAX2 Transcription Factor | 1 | 2013 | 81 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1997 | 605 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 11019 | 0.030 |
Why?
|
| Protein Kinase C | 1 | 1998 | 1334 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 411 | 0.030 |
Why?
|
| Genes, Bacterial | 1 | 1997 | 1152 | 0.030 |
Why?
|
| Ireland | 1 | 2012 | 164 | 0.030 |
Why?
|
| Fibroblasts | 2 | 2002 | 4345 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 1995 | 10439 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2018 | 1939 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2020 | 3713 | 0.030 |
Why?
|
| Biological Transport | 2 | 2009 | 2191 | 0.030 |
Why?
|
| MutS Homolog 2 Protein | 3 | 1997 | 188 | 0.030 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 450 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2000 | 2923 | 0.030 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 1994 | 184 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2000 | 1777 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 1995 | 2628 | 0.030 |
Why?
|
| Chickens | 1 | 2014 | 892 | 0.030 |
Why?
|
| Cell Division | 1 | 2000 | 4906 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 1281 | 0.030 |
Why?
|
| Oocytes | 2 | 2009 | 1224 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 1998 | 13469 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2009 | 1385 | 0.030 |
Why?
|
| Neuroglia | 1 | 1997 | 937 | 0.030 |
Why?
|
| Glycoproteins | 2 | 2009 | 2333 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2015 | 5778 | 0.030 |
Why?
|
| DNA, Bacterial | 1 | 1997 | 1572 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2009 | 1858 | 0.030 |
Why?
|
| Paclitaxel | 1 | 1998 | 1652 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2018 | 60991 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 1998 | 2173 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 3881 | 0.030 |
Why?
|
| Immune Sera | 1 | 1991 | 794 | 0.030 |
Why?
|
| Caenorhabditis elegans | 1 | 2000 | 1433 | 0.030 |
Why?
|
| Cause of Death | 1 | 2021 | 3582 | 0.030 |
Why?
|
| Precipitin Tests | 1 | 1991 | 920 | 0.030 |
Why?
|
| RNA | 1 | 2000 | 2493 | 0.030 |
Why?
|
| Occupations | 1 | 2012 | 505 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 2103 | 0.030 |
Why?
|
| Rats | 3 | 2015 | 25307 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 936 | 0.030 |
Why?
|
| Cell Cycle | 1 | 1998 | 3066 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 6970 | 0.020 |
Why?
|
| Conserved Sequence | 2 | 2008 | 1280 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 2503 | 0.020 |
Why?
|
| Body Patterning | 1 | 2014 | 652 | 0.020 |
Why?
|
| Health | 1 | 2012 | 394 | 0.020 |
Why?
|
| Antibodies | 1 | 1997 | 2421 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 1995 | 1867 | 0.020 |
Why?
|
| RNA, Viral | 1 | 1998 | 2823 | 0.020 |
Why?
|
| Protein Transport | 1 | 2015 | 2101 | 0.020 |
Why?
|
| 5' Flanking Region | 1 | 2008 | 34 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2015 | 7060 | 0.020 |
Why?
|
| Genital Neoplasms, Female | 1 | 1994 | 473 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1991 | 912 | 0.020 |
Why?
|
| Blood | 1 | 2011 | 628 | 0.020 |
Why?
|
| Herpes Simplex | 1 | 1992 | 475 | 0.020 |
Why?
|
| Kidney | 1 | 2004 | 6744 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1998 | 4441 | 0.020 |
Why?
|
| Ethics, Medical | 1 | 1994 | 811 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1996 | 2214 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2008 | 318 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 5044 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2009 | 448 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10766 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 4184 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2018 | 1907 | 0.020 |
Why?
|
| Vertebrates | 1 | 2008 | 226 | 0.020 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 3457 | 0.020 |
Why?
|
| Pharmacogenetics | 1 | 2011 | 675 | 0.020 |
Why?
|
| Dimerization | 1 | 2009 | 948 | 0.020 |
Why?
|
| Kinetics | 1 | 2015 | 6979 | 0.020 |
Why?
|
| Protein Conformation | 2 | 2009 | 4168 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 1994 | 1812 | 0.020 |
Why?
|
| Genome, Human | 1 | 2020 | 4458 | 0.020 |
Why?
|
| Workplace | 1 | 2012 | 811 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 2018 | 3425 | 0.020 |
Why?
|
| Recurrence | 1 | 2018 | 8198 | 0.020 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1996 | 2039 | 0.020 |
Why?
|
| Phenotype | 2 | 2020 | 16091 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2011 | 786 | 0.020 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1994 | 973 | 0.020 |
Why?
|
| Photoreceptor Cells, Invertebrate | 1 | 2005 | 43 | 0.020 |
Why?
|
| Genomics | 1 | 2021 | 4921 | 0.020 |
Why?
|
| Pyridines | 1 | 2018 | 2843 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2009 | 24351 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases | 1 | 2005 | 220 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 1009 | 0.020 |
Why?
|
| Retina | 1 | 2016 | 2627 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2000 | 3793 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 13204 | 0.020 |
Why?
|
| Deoxyuridine | 1 | 1983 | 36 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 6009 | 0.020 |
Why?
|
| Epithelium | 1 | 2008 | 1774 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3713 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2003 | 5114 | 0.020 |
Why?
|
| Metabolomics | 1 | 2011 | 1299 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2003 | 250 | 0.020 |
Why?
|
| Xenopus | 1 | 2005 | 787 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2016 | 6814 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 1178 | 0.010 |
Why?
|
| Rabbits | 1 | 2009 | 5339 | 0.010 |
Why?
|
| Guanidines | 1 | 2003 | 206 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 2000 | 10329 | 0.010 |
Why?
|
| Health Surveys | 1 | 2012 | 4119 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 5252 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2016 | 5579 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2005 | 1455 | 0.010 |
Why?
|
| Sulfones | 1 | 2003 | 452 | 0.010 |
Why?
|
| Microspheres | 1 | 2002 | 797 | 0.010 |
Why?
|
| Venous Thromboembolism | 1 | 2011 | 1429 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2016 | 13603 | 0.010 |
Why?
|
| Pregnancy | 1 | 2000 | 25703 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2012 | 10108 | 0.010 |
Why?
|
| Spliceosomes | 1 | 1999 | 158 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2729 | 0.010 |
Why?
|
| Drosophila | 1 | 2005 | 1429 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3602 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 15597 | 0.010 |
Why?
|
| Cattle | 1 | 2003 | 4017 | 0.010 |
Why?
|
| Transgenes | 1 | 2000 | 1037 | 0.010 |
Why?
|
| Genotype | 1 | 2011 | 13073 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2011 | 8882 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 1055 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 1995 | 165 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 2 | 1991 | 9863 | 0.010 |
Why?
|
| Tyrosine | 1 | 2000 | 1525 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2005 | 2103 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 1998 | 13898 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1994 | 5354 | 0.010 |
Why?
|
| Time Factors | 1 | 1998 | 42271 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 1952 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2011 | 4958 | 0.010 |
Why?
|
| DNA Probes | 1 | 1995 | 579 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 20409 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 67320 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2011 | 6030 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1585 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1996 | 959 | 0.010 |
Why?
|
| Virus Replication | 1 | 2000 | 2589 | 0.010 |
Why?
|
| Templates, Genetic | 1 | 1991 | 269 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 1996 | 1011 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1991 | 839 | 0.010 |
Why?
|
| Skin | 1 | 2002 | 4456 | 0.010 |
Why?
|
| Multigene Family | 1 | 1992 | 1200 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1994 | 19153 | 0.010 |
Why?
|
| Plasmids | 1 | 1991 | 2518 | 0.000 |
Why?
|
| Macrophages | 1 | 2000 | 5748 | 0.000 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1996 | 2935 | 0.000 |
Why?
|
| Risk Factors | 1 | 2011 | 69278 | 0.000 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 1983 | 124 | 0.000 |
Why?
|
| Antigen-Antibody Complex | 1 | 1984 | 547 | 0.000 |
Why?
|
| Species Specificity | 1 | 1984 | 2683 | 0.000 |
Why?
|
| Structure-Activity Relationship | 1 | 1983 | 3313 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 1998 | 17071 | 0.000 |
Why?
|